Secondary outcomes included GLP-1-related complications (acute pancreatitis, gastroparesis, abnormal weight loss) and postoperative events (acute kidney injury (AKI), myocardial infarction (MI), transient ischemic attack (TIA), cerebral infarction, arrhythmia, and hypoglycemic events). The gene discussed is GLP1R; the disease is acute kidney injury.